2 results
Pending
The purpose of the study is to determine whether PICSO is safe and feasible using a femoral approach, and in what amount of cases PICSO is effective to increase collateral flow index (CFI).
Not approvedWill not start
The objectives of this study are to demonstrate that Nepafenac Ophthalmic Suspension, 0.3% is not inferior to Nepafenac Ophthalmic Suspension, 0.1% (NEVANAC®); Nepafenac Ophthalmic Suspension, 0.3% is superior to Nepafenac 0.3% Vehicle and NEVANAC…